Original language | English |
---|---|
Pages (from-to) | 145-149 |
Number of pages | 5 |
Journal | Expert Review of Clinical Pharmacology |
Volume | 14 |
Issue number | 2 |
DOIs | |
State | Published - 2021 |
Bibliographical note
Funding Information:The authors acknowledge Lorraine Maw at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA, who helped in editing the article. Can-Jun Ruan is supported by a 2019 NARSAD Young Investigator Award from the Brain & Behavior Research Foundation. The authors are grateful to the reviewers for providing useful suggestions for improving the article.
Funding
The authors acknowledge Lorraine Maw at the Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA, who helped in editing the article. Can-Jun Ruan is supported by a 2019 NARSAD Young Investigator Award from the Brain & Behavior Research Foundation. The authors are grateful to the reviewers for providing useful suggestions for improving the article.
Funders | Funder number |
---|---|
Brain and Behavior Research Foundation | |
National Alliance for Research on Schizophrenia and Depression |
Keywords
- clozapine/adverse effects
- clozapine/blood
- clozapine/metabolism
- clozapine/pharmacokinetics
- clozapine/toxicity
- fever
- infection
- mortality/drug effects
- pneumonia
- respiratory aspiration
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- Pharmacology (medical)